(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
Expiration Date: 2025-10-31
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
Expiration Date: 2025-10-31
2nd Annual Hawaii Cancer Conference
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
Expiration Date: 2025-10-24
Community Practice Connections™: 8th Annual School of Nursing Oncology™
Expiration Date: 2025-10-10
Community Practice Connections™: 25th Annual International Lung Cancer Congress
Expiration Date: 2025-10-01
What’s Next for HER2- and TROP2-Directed ADCs in Lung Cancer: How Emerging Trial Data will Impact our Clinics Today, and Tomorrow….
Expiration Date: 2025-09-30
Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real-World Settings, What’s Next for Emerging Novel Strategies
Expiration Date: 2025-09-30
Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management
Expiration Date: 2025-08-28
20th Annual New York Lung Cancers Symposium®
Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers
Expiration Date: 2025-07-31
Top 10 Oncogenic Drivers in NSCLC for 2024: Where Are We and Where Are We Going?
Expiration Date: 2025-07-12
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
Expiration Date: 2025-07-12
DLL3 as a Therapeutic Target in SCLC and Beyond: Rationale, Recent Data and Potential for Transformations in Care with T-Cell Engagers
Expiration Date: 2025-07-12
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
Expiration Date: 2025-07-12
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
Expiration Date: 2025-06-03
26th Annual International Lung Cancer Congress®
BURST CME™: How Are Emerging Biomarkers and Testing Methodologies Shaping Personalized Medicine in NSCLC?
Expiration Date: 2025-05-15
Navigating Current State-of-the Art NSCLC Patient Care From the Front Lines: Essentials for Oncology Nurses Today and Tomorrow
Expiration Date: 2025-05-15
Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights Into Predicting Pathologic Responses to Immunotherapies
Expiration Date: 2025-05-09